$MYGN
MYRIAD GENETICS INC Stock $mygn

$mygn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000089992324000041 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$213.3M	$211.5M
YoY Change	11.15%	15.26%
Cost Of Revenue	$63.50M	$64.40M
YoY Change	10.24%	11.42%
Gross Profit	$149.8M	$147.1M
YoY Change	11.54%	17.02%
Gross Profit Margin	70.23%	69.55%
Selling, General & Admin	$139.1M	$144.9M
YoY Change	2.2%	2.99%
% of Gross Profit	92.86%	98.5%
Research & Development	$28.50M	$27.10M
YoY Change	18.75%	27.83%
% of Gross Profit	19.03%	18.42%
Depreciation & Amortization	$4.800M	$4.600M
YoY Change	41.18%	-65.41%
% of Gross Profit	3.2%	3.13%
Operating Expenses	$167.6M	$172.0M
YoY Change	4.68%	6.24%
Operating Profit	-$20.00M	-$36.50M
YoY Change	-66.72%	0.83%
Interest Expense	-$400.0K	-$400.0K
YoY Change	-140.0%
% of Operating Profit
Other Income/Expense, Net	-$1.200M	-$700.0K
YoY Change	9.09%	-70.83%
Pretax Income	-$21.20M	-$37.20M
YoY Change	-65.36%	-67.96%
Income Tax	$900.0K	-$500.0K
% Of Pretax Income
Net Earnings	-$22.10M	-$36.70M
YoY Change	-63.95%	-68.39%
Net Earnings / Revenue	-10.36%	-17.35%
Basic Earnings Per Share	-$0.24	-$0.41
Diluted Earnings Per Share	-$0.24	-$0.41
COMMON SHARES
Basic Shares Outstanding	90.82M shares	90.51M shares
Diluted Shares Outstanding	90.90M shares	90.60M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$97.30M
YoY Change		-19.98%
Cash & Equivalents	$99.90M	$92.40M
Short-Term Investments		$4.900M
Other Short-Term Assets		$50.40M
YoY Change		30.91%
Inventory	$26.20M	$26.10M
Prepaid Expenses
Receivables	$125.7M	$117.8M
Other Receivables		$0.00
Total Short-Term Assets	$293.2M	$291.6M
YoY Change	10.47%	-0.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$115.4M	$116.3M
YoY Change	-4.39%	-46.8%
Goodwill	$286.3M	$286.3M
YoY Change	-0.1%	-0.31%
Intangibles	$312.5M	$319.5M
YoY Change	-12.37%	-10.95%
Long-Term Investments
YoY Change
Other Assets	$16.50M	$14.90M
YoY Change	4.43%	-32.58%
Total Long-Term Assets	$788.1M	$793.5M
YoY Change	-10.82%	-11.13%
TOTAL ASSETS
Total Short-Term Assets	$293.2M	$291.6M
Total Long-Term Assets	$788.1M	$793.5M
Total Assets	$1.081B	$1.085B
YoY Change	-5.9%	-8.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.60M	$33.30M
YoY Change	-12.68%	-16.33%
Accrued Expenses	$111.2M	$98.30M
YoY Change	-29.44%	-38.45%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$154.3M	$148.9M
YoY Change	-26.28%	-32.65%
LONG-TERM LIABILITIES
Long-Term Debt	$39.00M	$38.80M
YoY Change	1.3%	1.04%
Other Long-Term Liabilities	$34.30M	$34.60M
YoY Change	-15.31%	-81.67%
Total Long-Term Liabilities	$73.30M	$73.40M
YoY Change	-7.22%	-67.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$154.3M	$148.9M
Total Long-Term Liabilities	$73.30M	$73.40M
Total Liabilities	$349.6M	$344.6M
YoY Change	-24.93%	-23.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$714.3M	-$692.2M
YoY Change	19.39%	28.9%
Common Stock	$1.446B	$1.437B
YoY Change	12.36%	12.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$731.7M	$740.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.081B	$1.085B
YoY Change	-5.9%	-8.6%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$22.10M	-$36.70M
YoY Change	-63.95%	-68.39%
Depreciation, Depletion And Amortization	$4.800M	$4.600M
YoY Change	41.18%	-65.41%
Cash From Operating Activities	$3.000M	$1.100M
YoY Change	-113.57%	-222.22%
INVESTING ACTIVITIES
Capital Expenditures	$6.300M	$8.900M
YoY Change	-64.0%	-52.66%
Acquisitions
YoY Change
Other Investing Activities	$13.80M	$2.500M
YoY Change	-8.0%	-91.83%
Cash From Investing Activities	$7.500M	-$6.400M
YoY Change	-400.0%	-154.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.100M	2.400M
YoY Change	24.0%	-93.75%
NET CHANGE
Cash From Operating Activities	3.000M	1.100M
Cash From Investing Activities	7.500M	-6.400M
Cash From Financing Activities	-3.100M	2.400M
Net Change In Cash	7.400M	-2.900M
YoY Change	-127.31%	-105.88%
FREE CASH FLOW
Cash From Operating Activities	$3.000M	$1.100M
Capital Expenditures	$6.300M	$8.900M
Free Cash Flow	-$3.300M	-$7.800M
YoY Change	-91.67%	-60.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://www.myriad.com/20240630#TestingMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://www.myriad.com/20240630#TestingMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://www.myriad.com/20240630#TestingMember
CY2024Q2	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://www.myriad.com/20240630#TestingMember
CY2024Q2	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://www.myriad.com/20240630#TestingMember
CY2023Q2	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://www.myriad.com/20240630#TestingMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://www.myriad.com/20240630#TestingMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://www.myriad.com/20240630#TestingMember
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119000000.0	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	349500000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	286300000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	287400000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14900000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15400000	usd
CY2024Q2	us-gaap	Assets Assets	1085100000	usd
CY2023Q4	us-gaap	Assets Assets	1146500000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	33300000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	25800000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98300000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	113900000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16200000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	38500000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	91200000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97400000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34600000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41300000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	344600000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	363300000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90900000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89900000	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	900000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	900000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1435800000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1415500000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3700000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-692200000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-629500000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	740500000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	783200000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1085100000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1146500000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	211500000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	413700000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	364700000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	57800000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	128900000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	117000000.0	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27100000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21200000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52700000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43700000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	144900000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	140700000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	284900000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	292400000	usd
CY2024Q2	us-gaap	Legal Fees LegalFees	0	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	77500000	usd
	us-gaap	Legal Fees LegalFees	0	usd
CY2024Q2	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	11600000	usd
CY2023Q2	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	11600000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	248000000.0	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	297200000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	478100000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	530600000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-36500000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-113700000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-64400000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-165900000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	400000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	500000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000000.0	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1200000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-300000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2400000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1600000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000000.0	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-700000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2400000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2800000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37200000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116100000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-168700000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-500000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-400000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2100000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36700000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-116100000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-170800000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90300000	shares
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2200000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1000000.0	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	800000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-900000	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-1400000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-500000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-700000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-500000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36500000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-113200000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-62900000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-165900000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	885800000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-4900000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-54700000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	783200000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-8700000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12000000.0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-26000000.0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-500000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	760000000.0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2500000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14500000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36700000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	200000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	740500000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62700000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30800000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32700000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4400000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5800000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26500000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18700000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1600000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-700000	usd
	mygn	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	900000	usd
	mygn	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	2300000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	319500000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	38800000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4000000.0	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	64400000	usd
	us-gaap	Legal Fees LegalFees	77500000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1300000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63100000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90600000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81500000	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1500000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	835200000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2900000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11200000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-116100000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000000.0	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	735200000	usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5500000	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	10400000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	291600000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	313600000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56500000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61600000	usd
CY2024Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	4000000.0	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	148900000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	155900000	usd
CY2024Q2	mygn	Unrecognized Tax Benefits Net UnrecognizedTaxBenefitsNet	31100000	usd
CY2023Q4	mygn	Unrecognized Tax Benefits Net UnrecognizedTaxBenefitsNet	30200000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	183500000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	800000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	500000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1300000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1000000.0	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.10
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90600000	shares
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-700000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-1400000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12800000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	3100000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
	mygn	Asset Acquisition Gain Loss AssetAcquisitionGainLoss	2200000	usd
	mygn	Asset Acquisition Gain Loss AssetAcquisitionGainLoss	0	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1800000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1700000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	2100000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4500000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10100000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4900000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2300000	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	1400000	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	100000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-700000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5100000	usd
	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	0	usd
	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-16300000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9400000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10700000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-20100000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	65400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16000000.0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34100000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	11900000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	42300000	usd
	us-gaap	Payments For Software PaymentsForSoftware	5600000	usd
	us-gaap	Payments For Software PaymentsForSoftware	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4000000.0	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	88700000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	46400000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3000000.0	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9200000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5100000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	80000000.0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	40000000.0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	80000000.0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	0	usd
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	1400000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6400000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33500000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1500000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	500000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	-2300000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39700000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	46300000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140900000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66400000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101200000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112700000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the Company's total assets, total liabilities, stockholders' equity, or cash flows from operations.</span></div>
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	211500000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	183500000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	413700000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	364700000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	0	usd
CY2023Q2	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	0	usd
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	0	usd
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	6300000	usd
	mygn	Increase Decrease In Earnings Loss Per Share IncreaseDecreaseInEarningsLossPerShare	0.07
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	3000000	usd
CY2024Q2	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div>Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company limits its exposure to loss by placing its cash in financial institutions with high credit ratings. The Company's cash may consist of deposits held with banks that may at times exceed federally insured limits of $250,000 per customer. Substantially all of the Company’s accounts receivable are with companies in the healthcare industry, U.S. and state governmental agencies, and individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments.
CY2024Q2	mygn	Cash And Cash Equivalents Carrying Value Before Reclassification Of Assets Held For Sale CashAndCashEquivalentsCarryingValueBeforeReclassificationOfAssetsHeldForSale	94700000	usd
CY2024Q2	mygn	Cash And Cash Equivalents Fair Value Disclosure Before Reclassification Of Assets Held For Sale CashAndCashEquivalentsFairValueDisclosureBeforeReclassificationOfAssetsHeldForSale	94700000	usd
CY2024Q2	mygn	Cash And Cash Equivalents Amortized Cost Reclassification To Assets Held For Sale CashAndCashEquivalentsAmortizedCostReclassificationToAssetsHeldForSale	2300000	usd
CY2024Q2	mygn	Cash And Cash Equivalents Reclassification To Assets Held For Sale CashAndCashEquivalentsReclassificationToAssetsHeldForSale	2300000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92400000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	92400000	usd
CY2024Q2	mygn	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	97300000	usd
CY2024Q2	mygn	Investments And Cash Accumulated Gross Unrealized Gain Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q2	mygn	Investments And Cash Accumulated Gross Unrealized Loss Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2024Q2	us-gaap	Investments And Cash InvestmentsAndCash	97300000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132100000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	132100000	usd
CY2023Q4	mygn	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	141000000.0	usd
CY2023Q4	mygn	Investments And Cash Accumulated Gross Unrealized Gain Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q4	mygn	Investments And Cash Accumulated Gross Unrealized Loss Before Tax InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax	100000	usd
CY2023Q4	us-gaap	Investments And Cash InvestmentsAndCash	140900000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	4900000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	4900000	usd
CY2024Q2	mygn	Investments And Cash Amortized Cost Before Reclassification Of Assets Held For Sale InvestmentsAndCashAmortizedCostBeforeReclassificationOfAssetsHeldForSale	99600000	usd
CY2024Q2	mygn	Investments And Cash Before Reclassification Of Assets Held For Sale InvestmentsAndCashBeforeReclassificationOfAssetsHeldForSale	99600000	usd
CY2024Q2	mygn	Cash And Cash Equivalents Amortized Cost Reclassification To Assets Held For Sale CashAndCashEquivalentsAmortizedCostReclassificationToAssetsHeldForSale	2300000	usd
CY2024Q2	mygn	Cash And Cash Equivalents Reclassification To Assets Held For Sale CashAndCashEquivalentsReclassificationToAssetsHeldForSale	2300000	usd
CY2024Q2	mygn	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	97300000	usd
CY2024Q2	us-gaap	Investments And Cash InvestmentsAndCash	97300000	usd
CY2024Q2	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	11300000	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	5600000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5400000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	500000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	5800000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	-100000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	231400000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	238900000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	114300000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	119900000	usd
CY2024Q2	mygn	Property Plant And Equipment Net Before Reclassification Of Assets Held For Sale PropertyPlantAndEquipmentNetBeforeReclassificationOfAssetsHeldForSale	117100000	usd
CY2023Q4	mygn	Property Plant And Equipment Net Before Reclassification Of Assets Held For Sale PropertyPlantAndEquipmentNetBeforeReclassificationOfAssetsHeldForSale	119000000.0	usd
CY2024Q2	mygn	Property Plant And Equipment Net Reclassification Of Assets Held For Sale PropertyPlantAndEquipmentNetReclassificationOfAssetsHeldForSale	800000	usd
CY2023Q4	mygn	Property Plant And Equipment Net Reclassification Of Assets Held For Sale PropertyPlantAndEquipmentNetReclassificationOfAssetsHeldForSale	0	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119000000.0	usd
CY2024Q2	us-gaap	Depreciation Depreciation	4600000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	2700000	usd
	us-gaap	Depreciation Depreciation	9700000	usd
	us-gaap	Depreciation Depreciation	11400000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	287400000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	800000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-300000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	286300000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	800000	usd
CY2024Q2	mygn	Finite Lived Intangible Assets Gross Before Reclassification Of Assets Held For Sale FiniteLivedIntangibleAssetsGrossBeforeReclassificationOfAssetsHeldForSale	649400000	usd
CY2024Q2	mygn	Finite Lived Intangible Assets Accumulated Amortization Before Reclassification Of Assets Held For Sale FiniteLivedIntangibleAssetsAccumulatedAmortizationBeforeReclassificationOfAssetsHeldForSale	316800000	usd
CY2024Q2	mygn	Finite Lived Intangible Assets Net Before Reclassification Of Assets Held For Sale FiniteLivedIntangibleAssetsNetBeforeReclassificationOfAssetsHeldForSale	332600000	usd
CY2024Q2	mygn	Finite Lived Intangible Assets Gross Reclassification Of Assets Held For Sale FiniteLivedIntangibleAssetsGrossReclassificationOfAssetsHeldForSale	21600000	usd
CY2024Q2	mygn	Finite Lived Intangible Assets Accumulated Amortization Reclassification Of Assets Held For Sale FiniteLivedIntangibleAssetsAccumulatedAmortizationReclassificationOfAssetsHeldForSale	8500000	usd
CY2024Q2	mygn	Finite Lived Intangible Assets Net Reclassification Of Assets Held For Sale FiniteLivedIntangibleAssetsNetReclassificationOfAssetsHeldForSale	13100000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	627800000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	308300000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	319500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	645800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	296300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349500000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10600000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10600000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21400000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21300000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	45200000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49700000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	4600000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4600000	usd
CY2024Q2	mygn	Refunds Payable And Reserve Current RefundsPayableAndReserveCurrent	19700000	usd
CY2023Q4	mygn	Refunds Payable And Reserve Current RefundsPayableAndReserveCurrent	20100000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3100000	usd
CY2024Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	6400000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	5300000	usd
CY2024Q2	us-gaap	Litigation Reserve Current LitigationReserveCurrent	6000000.0	usd
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	6000000.0	usd
CY2024Q2	mygn	Lease Termination Accrual Current LeaseTerminationAccrualCurrent	4300000	usd
CY2023Q4	mygn	Lease Termination Accrual Current LeaseTerminationAccrualCurrent	4400000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14400000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20700000	usd
CY2024Q2	mygn	Accrued Liabilities Current Reclassification To Liabilities Held For Sale AccruedLiabilitiesCurrentReclassificationToLiabilitiesHeldForSale	2300000	usd
CY2023Q4	mygn	Accrued Liabilities Current Reclassification To Liabilities Held For Sale AccruedLiabilitiesCurrentReclassificationToLiabilitiesHeldForSale	0	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98300000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	113900000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2300000	usd
CY2024Q2	mygn	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	7500000	usd
CY2023Q4	mygn	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	7500000	usd
CY2024Q2	mygn	Legal Charges Pending Settlement Noncurrent LegalChargesPendingSettlementNoncurrent	24000000.0	usd
CY2023Q4	mygn	Legal Charges Pending Settlement Noncurrent LegalChargesPendingSettlementNoncurrent	24000000.0	usd
CY2024Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3900000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	7500000	usd
CY2024Q2	mygn	Other Liabilities Noncurrent Reclassification To Liabilities Held For Sale OtherLiabilitiesNoncurrentReclassificationToLiabilitiesHeldForSale	800000	usd
CY2023Q4	mygn	Other Liabilities Noncurrent Reclassification To Liabilities Held For Sale OtherLiabilitiesNoncurrentReclassificationToLiabilitiesHeldForSale	0	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34600000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41300000	usd
CY2024Q2	mygn	Legal Charges Pending Settlement Noncurrent LegalChargesPendingSettlementNoncurrent	24000000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000.0	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000.0	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90900000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	90900000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89900000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89900000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81200000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81200000	shares
	mygn	Stock Issued During Period Shares Share Based Payment Arrangement And Employee Stock Purchase Plans StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans	1000000.0	shares
	mygn	Stock Issued During Period Shares Share Based Payment Arrangement And Employee Stock Purchase Plans StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans	700000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	90900000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90900000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81900000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81900000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90600000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81700000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90300000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81500000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90600000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90300000	shares
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6200000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6200000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	700000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.38
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	700000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.38
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	500000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.38
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	100000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	14500000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	11200000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	26500000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18700000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-500000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.013
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-400000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.006
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2100000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.012
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1300000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1100000	usd
	us-gaap	Interest Paid Net InterestPaidNet	700000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	mygn	Change In Operating Lease Right Of Use Asset ChangeInOperatingLeaseRightOfUseAsset	-300000	usd
	mygn	Change In Operating Lease Right Of Use Asset ChangeInOperatingLeaseRightOfUseAsset	8400000	usd
	mygn	Change In Operating Lease Liability ChangeInOperatingLeaseLiability	-3100000	usd
	mygn	Change In Operating Lease Liability ChangeInOperatingLeaseLiability	8700000	usd
	mygn	Purchases Of Property Plant And Equipment And Capitalization Of Internal Use Software In Accounts Payable And Accrued Liabilities PurchasesOfPropertyPlantAndEquipmentAndCapitalizationOfInternalUseSoftwareInAccountsPayableAndAccruedLiabilities	1700000	usd
	mygn	Purchases Of Property Plant And Equipment And Capitalization Of Internal Use Software In Accounts Payable And Accrued Liabilities PurchasesOfPropertyPlantAndEquipmentAndCapitalizationOfInternalUseSoftwareInAccountsPayableAndAccruedLiabilities	7500000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92400000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102800000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	8800000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	9900000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101200000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112700000	usd
	mygn	Operating Lease Liability Current Terminated OperatingLeaseLiabilityCurrentTerminated	3100000	usd
	mygn	Asset Acquisition Gain Loss AssetAcquisitionGainLoss	2200000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000899923-24-000041-index-headers.html	Edgar Link	pending
0000899923-24-000041-index.html	Edgar Link	pending
0000899923-24-000041.txt	Edgar Link	pending
0000899923-24-000041-xbrl.zip	Edgar Link	pending
exhibit311-certificationof.htm	Edgar Link	pending
exhibit312-certificationof.htm	Edgar Link	pending
exhibit321-certificationpu.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mygn-20240630.htm	Edgar Link	pending
mygn-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
mygn-20240630_cal.xml	Edgar Link	unprocessable
mygn-20240630_def.xml	Edgar Link	unprocessable
mygn-20240630_lab.xml	Edgar Link	unprocessable
mygn-20240630_pre.xml	Edgar Link	unprocessable
mygn-20240630_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MYGN
MYRIAD GENETICS INC Stock $mygn

2024 Q3 Form 10-Q Financial Statement

#000089992324000041 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYGN MYRIAD GENETICS INC Stock $mygn

2024 Q3 Form 10-Q Financial Statement

#000089992324000041 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYGN
MYRIAD GENETICS INC Stock $mygn